Melfiat Alternatives Compared
| Melfiat (phendimetrazine) | Wegovy (semaglutide) | Semaglutide |
|
|---|
| Melfiat (phendimetrazine) | Wegovy (semaglutide) | Semaglutide |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Weight Loss (Obesity/Overweight). Melfiat may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Weight Loss (Obesity/Overweight), Cardiovascular Risk Reduction. Wegovy may also be used for purposes not listed in this medication guide. |
Prescription only
Semaglutide lowers blood sugar levels by mimicking the effects of GLP-1, a naturally occurring hormone that stimulates insulin secretion and lowers glucagon secretion from the liver. It is taken... View more |
Related suggestions Weight Loss (Obesity/Overweight)
|
|||||||
| More about Melfiat (phendimetrazine) | More about Wegovy (semaglutide) | More about Semaglutide | ||||||||
| Ratings & Reviews | ||||||||||
|
Be the first to share your experience with this drug. |
Wegovy has an average rating of 7.5 out of 10 from a total of 419 ratings on Drugs.com. 64% of reviewers reported a positive effect, while 17% reported a negative effect. |
Semaglutide has an average rating of 6.9 out of 10 from a total of 2361 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 21% reported a negative effect. |
||||||||
| Drug Class | ||||||||||
| Side Effects | ||||||||||
| Generic Availability | ||||||||||
|
N/A |
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Wegovy prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms Available | ||||||||||
|
N/A |
|
N/A |
||||||||
| Brand Names | ||||||||||
| Other phendimetrazine brands include: Bontril PDM | Other semaglutide brands include: Ozempic, Rybelsus | Ozempic, Rybelsus, Wegovy | ||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
|
3.7 hours |
168 hours |
168 hours |
||||||||
| CSA Schedule ** View glossary of terms | ||||||||||
|
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | ||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | ||||||||||
|
A total of 172 drugs are known to interact with Melfiat:
|
A total of 267 drugs are known to interact with Wegovy:
|
A total of 267 drugs are known to interact with Semaglutide:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||
|
||||||||||
| Disease Interactions | ||||||||||
| First Approval Date | ||||||||||
|
October 20, 1975 |
N/A |
December 05, 2017 |
||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||
|
N/A |
N/A |
|||||||||
| More Information | ||||||||||
| Patient resources | ||||||||||
| Professional Resources | ||||||||||
|
N/A |
||||||||||
| Related Treatment Guide | ||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.